As metformin did not significantly modify metabolic
parameters or insulin sensitivity when compared to placebo,
the favourable modulation of SIRT1 expression,
p70S6 phosphorylation, and the N-glycome may be interpreted
as independent from metabolic effects, although
the study has not been designed to address this issue.